BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9870793)

  • 1. Treatment of Helicobacter pylori infection to reduce gastric cancer incidence: uncertain benefits of a community based programme in Australia.
    Forbes GM; Threlfall TJ
    J Gastroenterol Hepatol; 1998 Nov; 13(11):1091-5. PubMed ID: 9870793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer.
    Fendrick AM; Chernew ME; Hirth RA; Bloom BS; Bandekar RR; Scheiman JM
    Arch Intern Med; 1999 Jan; 159(2):142-8. PubMed ID: 9927096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of eradication of Helicobacter pylori on gastric cancer prevention in healthy asymptomatic populations.
    Bae SE; Choi KD; Choe J; Kim SO; Na HK; Choi JY; Ahn JY; Jung KW; Lee J; Kim DH; Chang HS; Song HJ; Lee GH; Jung HY
    Helicobacter; 2018 Apr; 23(2):e12464. PubMed ID: 29345408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass eradication of
    Chiang TH; Chang WJ; Chen SL; Yen AM; Fann JC; Chiu SY; Chen YR; Chuang SL; Shieh CF; Liu CY; Chiu HM; Chiang H; Shun CT; Lin MW; Wu MS; Lin JT; Chan CC; Graham DY; Chen HH; Lee YC
    Gut; 2021 Feb; 70(2):243-250. PubMed ID: 32792335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori eradication as a preventive tool against gastric cancer.
    Hamajima N; Goto Y; Nishio K; Tanaka D; Kawai S; Sakakibara H; Kondo T
    Asian Pac J Cancer Prev; 2004; 5(3):246-52. PubMed ID: 15373702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.
    Parsonnet J; Harris RA; Hack HM; Owens DK
    Lancet; 1996 Jul; 348(9021):150-4. PubMed ID: 8684154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori infection in Japan: current status and future options.
    Graham DY; Kimura K; Shimoyama T; Takemoto T
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S1-4. PubMed ID: 7735923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer.
    Fuccio L; Zagari RM; Minardi ME; Bazzoli F
    Aliment Pharmacol Ther; 2007 Jan; 25(2):133-41. PubMed ID: 17229238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results.
    Yeh JM; Kuntz KM; Ezzati M; Goldie SJ
    Int J Cancer; 2009 Jan; 124(1):157-66. PubMed ID: 18823009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
    Lee YC; Chiang TH; Chou CK; Tu YK; Liao WC; Wu MS; Graham DY
    Gastroenterology; 2016 May; 150(5):1113-1124.e5. PubMed ID: 26836587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
    JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy for eliminating gastric cancer in Japan.
    Asaka M; Kato M; Graham DY
    Helicobacter; 2010 Dec; 15(6):486-90. PubMed ID: 21073603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population based Helicobacter pylori screening and eradication: advances versus side effects.
    Tepes B
    Curr Pharm Des; 2014; 20(28):4501-9. PubMed ID: 24180403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifetime incidence risk for gastric cancer in the Helicobacter pylori-infected and uninfected population in Japan: A Monte Carlo simulation study.
    Kawai S; Wang C; Lin Y; Sasakabe T; Okuda M; Kikuchi S
    Int J Cancer; 2022 Jan; 150(1):18-27. PubMed ID: 34449868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should we screen for Helicobacter pylori to prevent gastric cancer?
    Leja M; Dumitrascu DL
    Dig Dis; 2007; 25(3):218-21. PubMed ID: 17827943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical epidemiology of gastric cancer.
    Ang TL; Fock KM
    Singapore Med J; 2014 Dec; 55(12):621-8. PubMed ID: 25630323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asia-Pacific consensus guidelines on gastric cancer prevention.
    Fock KM; Talley N; Moayyedi P; Hunt R; Azuma T; Sugano K; Xiao SD; Lam SK; Goh KL; Chiba T; Uemura N; Kim JG; Kim N; Ang TL; Mahachai V; Mitchell H; Rani AA; Liou JM; Vilaichone RK; Sollano J;
    J Gastroenterol Hepatol; 2008 Mar; 23(3):351-65. PubMed ID: 18318820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and gastric cancer.
    Parsonnet J
    Gastroenterol Clin North Am; 1993 Mar; 22(1):89-104. PubMed ID: 8449573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Could Helicobacter pylori treatment reduce stomach cancer risk?].
    Bretagne JF
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):440-52. PubMed ID: 12700501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: test and treat or test and scope for Helicobacter pylori infection. Any change in gastric cancer prevention?
    Mc Loughlin RM; Sebastian SS; O'Connor HJ; Buckley M; O'Morain CA
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():82-8. PubMed ID: 12786618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.